American Journal of Physiology -- Legacy Content 1993-07-01

Whole cell Cl- currents in human neutrophils induced by cell swelling.

J S Stoddard, J H Steinbach, L Simchowitz

Index: Am. J. Physiol. 265(1 Pt 1) , C156-65, (1993)

Full Text: HTML

Abstract

The properties of the conductive Cl- transport pathway underlying regulatory volume decrease (RVD) in human neutrophils were investigated using the whole cell patch-clamp technique. Cell swelling was induced during whole cell recordings by making the patch pipette solution hyperosmotic (approximately 20%) relative to the bath by addition of sucrose. Immediately after establishment of the whole cell configuration, no measurable Cl- currents were evident. Over a period of several minutes the outwardly rectifying Cl- current that developed displayed no apparent voltage dependence of activation and did not inactivate with time during voltage steps over the range of -80 to +80 mV. Reduction of Cl- currents by application of suction to the interior of the pipette implied that the swelling-induced Cl- channels are activated by membrane stretch. Based on reversal potential measurements, the volume-induced Cl- conductance was found to discriminate poorly among Cl-, Br-, I-, and NO3-, to possess a finite permeability to glucuronate (Pglucuronate/PCl approximately 0.1) and to be impermeable to cations. Single-channel conductance was estimated to be 1.5 pS from analysis of the variance of membrane current fluctuations. The activated Cl- currents were blocked by 100 microM of the compound MK-447 analogue A (inhibitor constant Ki = 37 microM) and by 200 microM 3,5-diiodosalicylate, 500 microM 4-acetamido-4'-iodothiocyanostilbene-2,2'-disulfonic acid, and 200 microM UK-5099. These results suggest that the initial event triggering RVD in neutrophils may be activation of stretch sensitive Cl- channels in the plasma membrane.

Related Compounds

Structure Name/CAS No. Articles
LITHIUM 3,5-DIIODOSALICYLATE Structure LITHIUM 3,5-DIIODOSALICYLATE
CAS:653-14-5
3,5-Diiodosalicylic acid Structure 3,5-Diiodosalicylic acid
CAS:133-91-5
UK-5099 Structure UK-5099
CAS:56396-35-1